HNSA · Hansa Biopharma AB
Market Cap
3.21B SEK
Shares
99.73M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close33.2200 SEK
Open33.1600 SEK
Day33.1000–33.9800 SEK
52W close24.8800–46.6800 SEK
Avg vol 30d611K
Last earningsJul 22, 2026
DataJan 2020–Oct 2026
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 24.8800 SEK
Now 33.2200 SEK · 38%
Range high 46.6800 SEK
vs 200-day avg -2%
vs 50-day avg -15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| XSTO:HNSA | -0.8% | -28.0% | +13.5% | -0.8% | -3.3% |
Exchange listing
- Market
- XSTO
- Ticker
- HNSA
- ISIN
- SE0002148817
- Security
- —
- Trading currency
- SEK
Company
- Investor relations
- https://www.hansabiopharma.com/investors
Other listings of this company
No other verified listings are available.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
No upcoming investor events are listed for this company yet.
Earnings calls
-
Capital Markets Day · July 2026 2026-07-24Hansa Biopharma Corporate Presentation July 2026
-
Earnings call · Q2 2026 2026-07-22Interim Report January-June 2026 Conference Call
-
Capital Markets Day · July 2026 2026-07-02Hansa Biopharma Corporate Presentation June 2026
-
Conference · March 2026 2026-03-13 Audio TranscriptLeerink Global Healthcare Conference - Hansa Biopharma Fireside Chat
-
Earnings call · Q4 2025 2026-02-11Q4 Earnings Report 2025 Presentation